MktsMarkets

Q32 Bio Inc.
NASDAQ: QTTBKey statistics
QTTB News
Stories mentioning QTTB from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 0.00 | 0.00 | 0.00 | |||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Operating Expenses | ||||||||
| Research & Development | 3,218 | 3,316 | 3,555 | 5,161 | 7,124 | 10,545 | 14,346 | 13,411 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 7,722 | 7,859 | 7,577 | 9,171 | 12,228 | 14,526 | 18,814 | 17,919 |
| Operating Income (Loss) | (7,722) | 45,878 | (7,577) | (9,171) | (12,228) | (14,526) | (18,814) | (17,919) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 113.00 | 115.00 | 188.00 | (318.00) | 1,197 | 358.00 | 1,219 | 2,390 |
| Pretax Income | ||||||||
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 21.00 | 0.00 | 0.00 |
| Net Income (Loss) | (7,609) | 57,730 | (7,389) | (9,489) | (11,031) | (14,189) | (17,595) | (16,978) |
| Earnings Per Share (Basic) | (0.54) | 4.69 | (0.60) | (0.78) | (0.90) | (1.52) | (1.46) | (1.42) |
| Earnings Per Share (Diluted) | (0.54) | 4.69 | (0.60) | (0.78) | (0.90) | (1.47) | (1.46) | (1.42) |
| Weighted Average Shares Outstanding (Basic) | 14,095 | 12,301 | 12,241 | 12,198 | 12,198 | 9,321 | 12,076 | 11,964 |
| Weighted Average Shares Outstanding (Diluted) | 14,095 | 12,315 | 12,241 | 12,198 | 12,198 | 9,658 | 12,076 | 11,964 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About QTTB
Q32 Bio Inc. (NASDAQ: QTTB) is a stock listed on the Nasdaq Stock Market under the ticker symbol QTTB. It last traded at $8.82 (Oct 30, 2026, 2:24 PM ET), down 0.6% on the day. That gives Q32 Bio a market capitalisation of $265.4M and a price-to-earnings ratio of 8.9.
Over the past 52 weeks QTTB has traded between $1.91 and $23.57.
For the quarter ended Mar 31, 2026 it reported a net loss of $7.6M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$7.6M |
| Dec 31, 2025 | — | $57.7M |
| Sep 30, 2025 | — | -$7.4M |
| Jun 30, 2025 | — | -$9.5M |
From Q32 Bio’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…